drugset / Trial / NCT02011737

Naftopidil 75mg for Improving Clearance of Urinary Stones

NCT02011737

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate Efficacy and Safety of oral intake of Naftopidil 75mg once daily for the improving clearance of ureteral or renal stones.

Timeline

Start
2014-02
Primary completion
2015-02
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Naftopidil Small molecule 75 mg Oral